<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.0.2" -->
<rss version="0.92">
<channel>
	<title>primary pulmonary hypertension</title>
	<link>http://www.your-news-blog.com/primary-pulmonary-hypertension</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Thu, 07 Aug 2008 13:32:43 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Exercise-induced pulmonary hypertension common in systemic sclerosis - Medicexchange  (Primary Pulmonary Hypertension News)</title>
		<description>Exercise-induced pulmonary hypertension  common in systemic sclerosisMedicexchange,&#160;UK&#160;- 2 hours agoPulmonary arterial hypertension (PAH) can often become apparent during exercise testing in patients with systemic sclerosis, according to a report in the ... Read More...dBTechnoUninsured And Chronically ill: The New American Health RiskThe Money Times,&#160;India&#160;- Aug 5, 2008... ambit of ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/07/exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis-medicexchange-primary-pulmonary-hypertension-news/</link>
			</item>
	<item>
		<title>EU Extends Indication of Bosentan to Pulmonary Arterial &#8230; - DG News  (Primary Pulmonary Hypertension News)</title>
		<description>EU Extends Indication of Bosentan to Pulmonary Arterial ...DG News&#160;- 10 hours ago... for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH World Health Organization [WHO] functional class [FC] II). ... Read More...WKU To Induct Three Into Hall Of Distinguished AlumniAmplifier,&#160;KY&#160;- 3 hours ago... Sharron H. Francisfrancis ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news-2/</link>
			</item>
	<item>
		<title>EU Extends Indication of Bosentan to Pulmonary Arterial &#8230; - DG News  (Primary Pulmonary Hypertension News)</title>
		<description>EU Extends Indication of Bosentan to Pulmonary Arterial ...DG News&#160;- 10 hours ago... for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH World Health Organization [WHO] functional class [FC] II). ... Read More...Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary ...Medscape (subscription)&#160;- Jul 31, 2008Pulmonary arterial hypertension (PAH) ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news/</link>
			</item>
	<item>
		<title>One-Third of Uninsured Are Chronically Ill - U.S. News &#038; World Report  (Primary Pulmonary Hypertension News)</title>
		<description>One-Third of Uninsured Are Chronically IllU.S. News & World Report,&#160;DC&#160;- 16 hours agoOther conditions examined were asthma, high cholesterol, chronic obstructive pulmonary disease or a previous diagnosis of cancer. ... Read More...Sleep wellSouthtown Star,&#160;IL&#160;- 4 hours agoNow Sahloul is trying to help people rest easy at the new Southwest Sleep ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/05/one-third-of-uninsured-are-chronically-ill-us-news-world-report-primary-pulmonary-hypertension-news/</link>
			</item>
	<item>
		<title>Tracleer(R) (bosentan) Receives EU Approval For Treatment Of &#8230; - Medical News Today (press release)  (Primary Pulmonary Hypertension News)</title>
		<description>Tracleer(R) (bosentan) Receives EU Approval For Treatment Of ...Medical News Today (press release),&#160;UK&#160;- 15 hours agoThe primary endpoints for the EARLY trial were  changes in pulmonary vascular resistance (PVR) and exercise capacity as measured by a 6-minute walk test ...Tracleer® (bosentan) receives EU approval for treatment of ... Ad-Hoc-News ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/04/tracleerr-bosentan-receives-eu-approval-for-treatment-of-medical-news-today-press-release-primary-pulmonary-hypertension-news/</link>
			</item>
	<item>
		<title>Edmond teen fights back - Edmond Sun  (Primary Pulmonary Hypertension News)</title>
		<description>Edmond teen fights backEdmond Sun,&#160;OK&#160;- Aug 1, 2008EDMOND — Lauren Johnson, 16, looks like a normal teenager on the outside but daily fights the symptoms of a disease called pulmonary hypertension, ... Read More...Lung transplant recipient recoveringDubuque Telegraph Herald,&#160;IA&#160;- Jul 31, 2008Tuesday&#39;s procedure was Nick&#39;s second transplant. A rare lung ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/edmond-teen-fights-back-edmond-sun-primary-pulmonary-hypertension-news/</link>
			</item>
	<item>
		<title>Support Groups - Eagle Tribune  (Primary Pulmonary Hypertension News)</title>
		<description>Support GroupsEagle Tribune,&#160;MA&#160;- 1 hour agoAnyone interested in learning more about scleroderma and pulmonary hypertension is welcome. For more information, call Pat Gelinas at 329-8382 or the ... Read More...First half 2008 financial results: NicOx nears completion of phase ...FOXBusiness&#160;- Jul 28, 2008The two studies have recruited a total of ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/support-groups-eagle-tribune-primary-pulmonary-hypertension-news/</link>
			</item>
	<item>
		<title>New Eloxatin(R) and Taxotere(R) Data in Several Tumor Types to Be - PR Newswire  (Primary Pulmonary Hypertension News)</title>
		<description>- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting's scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that key study results from the company's    Read More Background: In 1999, the country began a political, legal, economical and social ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/02/new-eloxatinr-and-taxoterer-data-in-several-tumor-types-to-be-pr-newswire-primary-pulmonary-hypertension-news-7/</link>
			</item>
	<item>
		<title>Financial Results for Full Year 2007: NicOx Significantly Advances - PR Newswire  (Primary Pulmonary Hypertension News)</title>
		<description>SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ -- NicOx S.A. Euronext: COX Paris: COX today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of    Read More CHICAGO, July 29, 2008 – Elan Corporation, plc ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/financial-results-for-full-year-2007-nicox-significantly-advances-pr-newswire-primary-pulmonary-hypertension-news-2/</link>
			</item>
	<item>
		<title>Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial - MSN MoneyCentral  (Primary Pulmonary Hypertension News)</title>
		<description>Elan Corporation, plc ELN and Wyeth WYE today are presenting detailed results from the companies ’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer's disease at the Alzheimer ’ s Association ’ s    Read More IRVINE, Calif., Feb. 20 /PRNewswire/ -- ...</description>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/elan-and-wyeth-present-encouraging-results-from-phase-2-clinical-trial-msn-moneycentral-primary-pulmonary-hypertension-news/</link>
			</item>
</channel>
</rss>
